Playback speed
10 seconds
ASCO® 2023 Insights: "Novel FolRα-Targeting ADC Luveltamab Tazevibulin in Recurrent Epithelial Ovarian Cancer"
By
ecancer
FEATURING
Ana Oaknin
By
ecancer
FEATURING
Ana Oaknin
80 views
June 15, 2023
Comments 0
Login to view comments.
Click here to Login